Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen M Barry

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Msystems|April 5, 2019
Genome and Functional Characterization of Colonization Factor Antigen I- and CS6-Encoding Heat-Stable Enterotoxin-Only Enterotoxigenic <i>Escherichia coli</i> Reveals Lineage and Geographic VariationTracy H Hazen, Sushma Nagaraj, Sunil Sen, et al.
Infection and Immunity|June 6, 2018
Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli InfectionSerena Giuntini, Matteo Stoppato, Maja Sedic, et al.
Infection and Immunity|November 22, 2018
Correction for Giuntini et al., "Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection"Serena Giuntini, Matteo Stoppato, Maja Sedic, et al.
NPJ Vaccines|April 8, 2020
A bivalent vaccine confers immunogenicity and protection against <i>Shigella flexneri</i> and enterotoxigenic <i>Escherichia coli</i> infections in micePedro Henrique Q S Medeiros, David T Bolick, Solanka E Ledwaba, et al.
Msphere|August 3, 2018
A Novel <i>Shigella</i> Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental ChallengeEsther Ndungo, Arlo Randall, Tracy H Hazen, et al.
Human Vaccines|October 17, 2007
Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free mediaKaren L Kotloff, Jakub K Simon, Marcela F Pasetti, et al.
Clinical and Vaccine Immunology : CVI|December 20, 2013
Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainKatharina Richard, Barbara J Mann, Lenea Stocker, et al.
Pathogens (Basel, Switzerland)|December 28, 2021
The O-Ag Antibody Response to Francisella Is Distinct in Rodents and Higher Animals and Can Serve as a Correlate of ProtectionLauren E Shoudy, Prachi Namjoshi, Gabriela Giordano, et al.
The Journal of Infectious Diseases|April 18, 2026
First-in-Human Evaluation of the Safety, Genetic Stability, and Immunogenicity of an Attenuated Shigella flexneri 2a Live Vector Expressing Enterotoxigenic Escherichia coli Antigens, Vaccine Strain CVD 1208S-122Wilbur H Chen, Eileen M Barry, Franklin R Toapanta, et al.
Gut Microbes|February 5, 2019
A murine model of diarrhea, growth impairment and metabolic disturbances with <i>Shigella flexneri</i> infection and the role of zinc deficiencyPedro Henrique Q S Medeiros, Solanka E Ledwaba, David T Bolick, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Msystems|April 5, 2019
Genome and Functional Characterization of Colonization Factor Antigen I- and CS6-Encoding Heat-Stable Enterotoxin-Only Enterotoxigenic <i>Escherichia coli</i> Reveals Lineage and Geographic VariationTracy H Hazen, Sushma Nagaraj, Sunil Sen, et al.
Infection and Immunity|June 6, 2018
Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli InfectionSerena Giuntini, Matteo Stoppato, Maja Sedic, et al.
Infection and Immunity|November 22, 2018
Correction for Giuntini et al., "Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection"Serena Giuntini, Matteo Stoppato, Maja Sedic, et al.
NPJ Vaccines|April 8, 2020
A bivalent vaccine confers immunogenicity and protection against <i>Shigella flexneri</i> and enterotoxigenic <i>Escherichia coli</i> infections in micePedro Henrique Q S Medeiros, David T Bolick, Solanka E Ledwaba, et al.
Msphere|August 3, 2018
A Novel <i>Shigella</i> Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental ChallengeEsther Ndungo, Arlo Randall, Tracy H Hazen, et al.
Human Vaccines|October 17, 2007
Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free mediaKaren L Kotloff, Jakub K Simon, Marcela F Pasetti, et al.
Clinical and Vaccine Immunology : CVI|December 20, 2013
Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainKatharina Richard, Barbara J Mann, Lenea Stocker, et al.
Pathogens (Basel, Switzerland)|December 28, 2021
The O-Ag Antibody Response to Francisella Is Distinct in Rodents and Higher Animals and Can Serve as a Correlate of ProtectionLauren E Shoudy, Prachi Namjoshi, Gabriela Giordano, et al.
The Journal of Infectious Diseases|April 18, 2026
First-in-Human Evaluation of the Safety, Genetic Stability, and Immunogenicity of an Attenuated Shigella flexneri 2a Live Vector Expressing Enterotoxigenic Escherichia coli Antigens, Vaccine Strain CVD 1208S-122Wilbur H Chen, Eileen M Barry, Franklin R Toapanta, et al.
Gut Microbes|February 5, 2019
A murine model of diarrhea, growth impairment and metabolic disturbances with <i>Shigella flexneri</i> infection and the role of zinc deficiencyPedro Henrique Q S Medeiros, Solanka E Ledwaba, David T Bolick, et al.
Pageof 7